vs

Side-by-side financial comparison of BTCS Inc. (BTCS) and UTAH MEDICAL PRODUCTS INC (UTMD). Click either name above to swap in a different company.

UTAH MEDICAL PRODUCTS INC is the larger business by last-quarter revenue ($9.0M vs $7.1M, roughly 1.3× BTCS Inc.). On growth, BTCS Inc. posted the faster year-over-year revenue change (205.5% vs -1.2%). UTAH MEDICAL PRODUCTS INC produced more free cash flow last quarter ($3.4M vs $-9.8M). Over the past eight quarters, BTCS Inc.'s revenue compounded faster (296.4% CAGR vs -10.7%).

Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites...

BTCS vs UTMD — Head-to-Head

Bigger by revenue
UTMD
UTMD
1.3× larger
UTMD
$9.0M
$7.1M
BTCS
Growing faster (revenue YoY)
BTCS
BTCS
+206.7% gap
BTCS
205.5%
-1.2%
UTMD
More free cash flow
UTMD
UTMD
$13.2M more FCF
UTMD
$3.4M
$-9.8M
BTCS
Faster 2-yr revenue CAGR
BTCS
BTCS
Annualised
BTCS
296.4%
-10.7%
UTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTCS
BTCS
UTMD
UTMD
Revenue
$7.1M
$9.0M
Net Profit
$2.6M
Gross Margin
12.4%
58.2%
Operating Margin
27.0%
Net Margin
28.4%
Revenue YoY
205.5%
-1.2%
Net Profit YoY
-11.6%
EPS (diluted)
$-1.58
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTCS
BTCS
UTMD
UTMD
Q4 25
$7.1M
$9.0M
Q3 25
$4.9M
$9.8M
Q2 25
$2.8M
$10.0M
Q1 25
$1.7M
$9.7M
Q4 24
$2.3M
$9.2M
Q3 24
$739.2K
$10.0M
Q2 24
$561.2K
$10.4M
Q1 24
$451.4K
$11.3M
Net Profit
BTCS
BTCS
UTMD
UTMD
Q4 25
$2.6M
Q3 25
$65.6M
$2.6M
Q2 25
$3.9M
$3.0M
Q1 25
$-17.3M
$3.0M
Q4 24
$2.9M
Q3 24
$-9.0M
$3.6M
Q2 24
$-6.7M
$3.5M
Q1 24
$12.3M
$4.0M
Gross Margin
BTCS
BTCS
UTMD
UTMD
Q4 25
12.4%
58.2%
Q3 25
22.0%
57.1%
Q2 25
-2.9%
56.2%
Q1 25
7.1%
57.0%
Q4 24
2.9%
58.1%
Q3 24
26.5%
58.0%
Q2 24
69.9%
60.1%
Q1 24
64.4%
59.7%
Operating Margin
BTCS
BTCS
UTMD
UTMD
Q4 25
27.0%
Q3 25
26.6%
Q2 25
32.1%
Q1 25
32.5%
Q4 24
32.0%
Q3 24
33.4%
Q2 24
33.1%
Q1 24
34.2%
Net Margin
BTCS
BTCS
UTMD
UTMD
Q4 25
28.4%
Q3 25
1328.1%
26.8%
Q2 25
140.0%
30.6%
Q1 25
-1022.5%
31.3%
Q4 24
31.7%
Q3 24
-1223.0%
35.6%
Q2 24
-1198.9%
33.2%
Q1 24
2715.3%
34.9%
EPS (diluted)
BTCS
BTCS
UTMD
UTMD
Q4 25
$-1.58
$0.80
Q3 25
$1.30
$0.82
Q2 25
$0.14
$0.94
Q1 25
$-0.86
$0.92
Q4 24
$0.28
$0.86
Q3 24
$-0.56
$1.03
Q2 24
$-0.43
$0.98
Q1 24
$0.63
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTCS
BTCS
UTMD
UTMD
Cash + ST InvestmentsLiquidity on hand
$1.5M
$85.8M
Total DebtLower is stronger
$225.0K
Stockholders' EquityBook value
$139.4M
$119.3M
Total Assets
$214.6M
$122.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTCS
BTCS
UTMD
UTMD
Q4 25
$1.5M
$85.8M
Q3 25
$4.5M
$84.3M
Q2 25
$639.2K
$82.2M
Q1 25
$269.9K
$83.3M
Q4 24
$2.0M
$83.0M
Q3 24
$254.5K
$88.5M
Q2 24
$536.7K
$89.2M
Q1 24
$670.6K
$93.8M
Total Debt
BTCS
BTCS
UTMD
UTMD
Q4 25
$225.0K
Q3 25
Q2 25
Q1 25
$269.0K
Q4 24
$282.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BTCS
BTCS
UTMD
UTMD
Q4 25
$139.4M
$119.3M
Q3 25
$225.4M
$118.3M
Q2 25
$31.1M
$117.5M
Q1 25
$20.6M
$117.0M
Q4 24
$34.0M
$117.4M
Q3 24
$25.2M
$124.2M
Q2 24
$33.1M
$124.1M
Q1 24
$39.3M
$127.7M
Total Assets
BTCS
BTCS
UTMD
UTMD
Q4 25
$214.6M
$122.5M
Q3 25
$298.9M
$122.0M
Q2 25
$40.8M
$120.8M
Q1 25
$21.0M
$122.5M
Q4 24
$38.2M
$122.5M
Q3 24
$26.5M
$129.7M
Q2 24
$33.8M
$130.0M
Q1 24
$39.5M
$135.4M
Debt / Equity
BTCS
BTCS
UTMD
UTMD
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTCS
BTCS
UTMD
UTMD
Operating Cash FlowLast quarter
$-9.8M
$3.5M
Free Cash FlowOCF − Capex
$-9.8M
$3.4M
FCF MarginFCF / Revenue
-138.1%
37.2%
Capex IntensityCapex / Revenue
0.2%
1.2%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$-15.8M
$14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTCS
BTCS
UTMD
UTMD
Q4 25
$-9.8M
$3.5M
Q3 25
$-2.8M
$3.9M
Q2 25
$-1.3M
$2.9M
Q1 25
$-1.9M
$4.5M
Q4 24
$-3.5M
$2.9M
Q3 24
$-695.2K
$3.9M
Q2 24
$-924.1K
$2.8M
Q1 24
$-769.0K
$5.3M
Free Cash Flow
BTCS
BTCS
UTMD
UTMD
Q4 25
$-9.8M
$3.4M
Q3 25
$-2.8M
$3.9M
Q2 25
$-1.3M
$2.8M
Q1 25
$-1.9M
$4.3M
Q4 24
$-3.5M
$2.9M
Q3 24
$3.8M
Q2 24
$2.7M
Q1 24
$5.3M
FCF Margin
BTCS
BTCS
UTMD
UTMD
Q4 25
-138.1%
37.2%
Q3 25
-56.7%
39.2%
Q2 25
-48.2%
28.4%
Q1 25
-112.7%
44.1%
Q4 24
-152.2%
32.0%
Q3 24
37.7%
Q2 24
25.5%
Q1 24
46.3%
Capex Intensity
BTCS
BTCS
UTMD
UTMD
Q4 25
0.2%
1.2%
Q3 25
0.1%
0.3%
Q2 25
0.1%
0.5%
Q1 25
0.1%
1.9%
Q4 24
0.1%
0.1%
Q3 24
0.9%
Q2 24
1.1%
Q1 24
0.2%
Cash Conversion
BTCS
BTCS
UTMD
UTMD
Q4 25
1.36×
Q3 25
-0.04×
1.47×
Q2 25
-0.34×
0.94×
Q1 25
1.47×
Q4 24
1.01×
Q3 24
1.08×
Q2 24
0.80×
Q1 24
-0.06×
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTCS
BTCS

Builder Plus$5.9M83%
Other$1.2M17%

UTMD
UTMD

Segment breakdown not available.

Related Comparisons